EP Patent

EP2207526B1 — Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof

Assigned to Ferring International Center SA · Expires 2017-11-22 · 8y expired

What this patent protects

Patent listed against Renacidin.

Drugs covered by this patent

Patent Metadata

Patent number
EP2207526B1
Jurisdiction
EP
Classification
—
Expires
2017-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Ferring International Center SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.